Form 144 filed for GRMN: UBS to handle 1,718-share sale
Rhea-AI Filing Summary
Form 144 notice of proposed sale of securities by an insider of Garmin Ltd (GRMN). The filing reports a proposed sale of 1,718 common shares with an aggregate market value of $395,140, to be executed on the NYSE through UBS Financial Services Inc.
The securities were acquired in two stock releases: 342 shares from a performance stock release on 02/25/2021 and 1,376 shares from a restricted stock release on 12/15/2020. The issuer's reported shares outstanding are 192,493,945. The filer reports no securities sold in the past three months and makes the required representation that they are not aware of any material nonpublic information about the issuer.
Positive
- Regulatory compliance: Insider filed a Form 144, demonstrating adherence to Rule 144 disclosure requirements.
- No recent sales: The filing states "Nothing to Report" for securities sold during the past three months.
Negative
- None.
Insights
TL;DR: Routine Form 144 disclosing a small insider sale; no recent related sales reported.
The filing documents a proposed sale of 1,718 common shares via UBS on the NYSE, with an aggregate market value of $395,140. The shares were acquired in two stock releases in 2020 and 2021. The filing also states no sales in the prior three months, and lists total outstanding shares of 192,493,945. From a market-impact perspective, the disclosed amount appears limited relative to the issuer's outstanding shares and reads as a routine insider monetization disclosure rather than a material corporate development.
TL;DR: The Form 144 shows compliance with disclosure rules and includes the standard insider attestation.
The filer provided the required particulars: broker (UBS Financial Services), planned sale date (listed for 08/11/2025), acquisition dates and types (performance and restricted stock releases), and a certification about material nonpublic information. This completeness supports regulatory transparency. The notice contains no indication of accelerated or aggregated sales that would signal an unusual governance concern.